HK Inno.N Corp - ESG Rating & Company Profile powered by AI
The ESG rating for HK Inno.N Corp represents the company's transparency towards the United Nations SDGs. The webpage contains a free E,S&G report for HK Inno.N Corp. Alternative corporations in the scoring peer group for HK Inno.N Corp are displayed below.
HK Inno.N Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | HK Inno.N Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does HK Inno.N Corp have an accelerator or VC vehicle to help deliver innovation?
Does HK Inno.N Corp disclose current and historical energy intensity?
Does HK Inno.N Corp report the average age of the workforce?
Does HK Inno.N Corp reference operational or capital allocation in relation to climate change?
Does HK Inno.N Corp disclose its ethnicity pay gap?
Does HK Inno.N Corp disclose cybersecurity risks?
Does HK Inno.N Corp offer flexible work?
Does HK Inno.N Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does HK Inno.N Corp disclose the number of employees in R&D functions?
Does HK Inno.N Corp conduct supply chain audits?
Does HK Inno.N Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does HK Inno.N Corp conduct 360 degree staff reviews?
Does HK Inno.N Corp disclose the individual responsible for D&I?
Does HK Inno.N Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does HK Inno.N Corp disclose current and / or historical scope 2 emissions?
Does HK Inno.N Corp disclose water use targets?
Does HK Inno.N Corp have careers partnerships with academic institutions?
Did HK Inno.N Corp have a product recall in the last two years?
Does HK Inno.N Corp disclose incidents of discrimination?
Does HK Inno.N Corp allow for Work Councils/Collective Agreements to be formed?
Has HK Inno.N Corp issued a profit warning in the past 24 months?
Does HK Inno.N Corp disclose parental leave metrics?
Does HK Inno.N Corp disclose climate scenario or pathway analysis?
Does HK Inno.N Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does HK Inno.N Corp disclose the pay ratio of women to men?
Does HK Inno.N Corp support suppliers with sustainability related research and development?
Does HK Inno.N Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does HK Inno.N Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is HK Inno.N Corp involved in embryonic stem cell research?
Does HK Inno.N Corp disclose GHG and Air Emissions intensity?
Does HK Inno.N Corp disclose its waste policy?
Does HK Inno.N Corp report according to TCFD requirements?
Does HK Inno.N Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does HK Inno.N Corp disclose energy use targets?
Does HK Inno.N Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does HK Inno.N Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for HK Inno.N Corp
These potential risks are based on the size, segment and geographies of the company.
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers drugs for the treatment of GERD, EE, NERD, GU and H.Pylori; hypertension and dyslipidemia; diabetes with dyslipidemia; blood pressure; bacterial infections, such as pneumonia, skin infections, or blood infections; anti-cancer; antidepressants; urology; and renal disease, intravenous nutrition, and infusion, as well as provides antibiotics. It also provides active pharmaceutical ingredients, and drinks and health functional foods. The company also exports its products to Japan, Southeast Asia, Central and South America, Europe, and Vietnam. HK inno.N Corporation was founded in 1984 and is headquartered in Seoul, South Korea.